Products & Services · Percent Change (as a percent)

Tecvayli — Percent Change (as a percent)

Johnson & Johnson Tecvayli — Percent Change (as a percent) increased by 7.0% to 33.5% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 151.9%, from 13.3% to 33.5%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2024
Last reportedQ1 2026Apr 22, 2026

How to read this metric

A positive percentage indicates accelerating sales momentum and market penetration, whereas a negative percentage suggests a deceleration in growth or potential market saturation.

Detailed definition

This metric measures the period-over-period percentage growth or decline in net sales for the Tecvayli product line. It...

Peer comparison

Comparable to year-over-year or quarter-over-quarter revenue growth rates for specific high-growth pharmaceutical products across the industry.

Metric ID: jnj_segment_tecvayli_percent_change_as_a_percent

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value76.7%42.9%20.6%13.3%23.1%31.3%33.5%
QoQ Change-44.1%-52.0%-35.4%+73.7%+35.5%+7.0%
YoY Change-82.7%-46.2%+51.9%+151.9%
Range13.3%76.7%
CAGR-42.4%
Avg YoY Growth+18.8%
Median YoY Growth+2.9%
Current Streak3 quarters growth

Frequently Asked Questions

What is Johnson & Johnson's tecvayli — percent change (as a percent)?
Johnson & Johnson (JNJ) reported tecvayli — percent change (as a percent) of 33.5% in Q1 2026.
How has Johnson & Johnson's tecvayli — percent change (as a percent) changed year-over-year?
Johnson & Johnson's tecvayli — percent change (as a percent) increased by 151.9% year-over-year, from 13.3% to 33.5%.
What does tecvayli — percent change (as a percent) mean?
The percentage growth or decline in sales for the Tecvayli product compared to a previous period.